Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Confirm those rules before checkout
These frequently asked questions address common topics about this product, including what it is, how it is typically used, who may consider it, and how it compares to related options
Two likely scenarios: New permanent rules are finalized before the extension expires, establishing clear pathways for telemedicine prescribing of controlled substances (probably requiring special registration or state-matching) Another extension is granted while rules are still being developed (this has happened four times already) What you should do now: Build your practice around non-controlled medications (GLP-1s) as the foundation If using controlled substances (phentermine), have a backup plan: either transition patients to in-person visits for medication management or switch to non-controlled alternatives Monitor DEA proposed rulemaking (watch for Federal Register notices in 2026) Join professional associations that lobby for permanent telehealth access (APA, AMA, AANP) Is there higher regulatory risk with telehealth weight-loss prescribing
Some patients pay cash if they have the financial means and no other options
A person with a history of bowel problems on pancreatitis probably shouldn't be taking a GLP-1 agonist, she noted
US$ 26.68
US$ 26.88
US$ 24.92
US$ 20.99
US$ 24.37
